Back to search

Article

Association of polymorphisms of ApoE, ApoA1, PCSK9 with LDL-C modification following Atorvastatin therapy in dyslipidemic patients.

2026-02-25

Abstract excerpt

<title>Abstract</title> <p>Dyslipidemia, a risk factor for atherosclerotic cardiovascular disease, is primarily managed by statins. Single-nucleotide polymorphisms (SNPs) may influence LDL-C reduction variability seen with statins. Treatment-naïve adult dyslipidemic patients prescribed Atorvastatin (40/80mg) were enrolled in a 12-week observational study. Lipid profiles were estimated at baseline & follow-up (wee...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5fad485f-7993-514a-aea8-2a9236b58ef7
DOI
10.21203/rs.3.rs-8727328/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Association of polymorphisms of ApoE, ApoA1, PCSK9 with LDL-C modification following Atorvastatin therapy in dyslipidemic patients.DOI 10.21203/rs.3.rs-8727328/v1
APOE genotype and the effect of statins: a systematic review and meta-analysisSemantic proximity
Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response.Semantic proximity
Gene-drug interactions identify genomic loci that enhance statin effectiveness in lowering LDL cholesterolSemantic proximity
Genetic contribution to lipid target achievement with statin therapy: a prospective study.Semantic proximity
Genetic and gender factor affect lipid profiles of patients receiving statin treatment in the east coast region of Peninsular MalaysiaSemantic proximity
Association of APOE polymorphisms with lipid-lowering efficacy of statins in atherosclerotic cardiovascular diseases.Semantic proximity
CYP7A1 polymorphism influences the LDL cholesterol-lowering response to atorvastatin.Semantic proximity
Gene-statin interaction study identifies 9 loci that moderate statin effectiveness in blood lipidsSemantic proximity
APOE genotype and the effect of statins on lipid outcomes: A meta-analysis.Semantic proximity
Statins personalized.Semantic proximity
Genetic determinants of lipid-lowering response to atorvastatin therapy in an Indian population.Semantic proximity
The Association between Single Nucleotide Polymorphisms, including miR-499a Genetic Variants, and Dyslipidemia in Subjects Treated with Pharmacological or Phytochemical Lipid-Lowering Agents.Semantic proximity
Select a neighboring publication to make it the new centre.